HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intraclonal diversity in a Sezary syndrome with a differential response to 2-deoxycoformycin of the two lymphoma cell populations.

Abstract
We report a case of Sezary syndrome with two abnormal CD4+ T-cell populations detected in the peripheral blood by flow cytometry immunophenotyping and DNA cell content, suggesting a biclonal T-cell lymphoproliferative disorder. Despite these findings, molecular analysis of the T-cell receptor genes was consistent with a monoclonal T-cell proliferation, supporting the existence of intraclonal diversity rather than a true biclonal disease. The patient achieved a transient response with 2-deoxycoformycin, with a selective decrease of the larger/hyperploid T-cell population; later on, an increased representation of this T-cell population was observed concomitantly with clinical relapse.
AuthorsElisa Granjo, Margarida Lima, José Manuel Lopes, Nória Cunha, Maria Dos Anjos Teixeira, Filipe Santos, Jorge Candeias, Carlos Resende, Ana Helena Santos, Ana Balanzategui, Alberto Orfão, Estella Matutes
JournalBritish journal of haematology (Br J Haematol) Vol. 119 Issue 3 Pg. 629-33 (Dec 2002) ISSN: 0007-1048 [Print] England
PMID12437636 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Pentostatin
Topics
  • Aged
  • Antibiotics, Antineoplastic (therapeutic use)
  • CD4-Positive T-Lymphocytes (immunology)
  • Cell Division
  • Flow Cytometry
  • Humans
  • Immunophenotyping (methods)
  • Male
  • Pentostatin (therapeutic use)
  • Phenotype
  • Sezary Syndrome (drug therapy, immunology)
  • Skin Neoplasms (drug therapy, immunology)
  • T-Lymphocyte Subsets (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: